Table 4 Association (Odds Ratio (95% CI)) of socio-demographic, seasonal, behavioural, and health-related factors with circadian rhythm clusters in the UK Biobank accelerometer sub-studya
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | Cluster 7 | Cluster 8 | Cluster 9 | |
|---|---|---|---|---|---|---|---|---|---|
RAR ++ PA ++ | RAR + PA + Sleep - | RAR + LIPA + Sleep + | MVPA ++ | RAR - Chronotype -- | RAR - PA - Sleep + | RAR - PA - Sleep -- | RAR - PA + Restless sleep | RAR -- PA -- Chronotype - | |
N | 5431 (10.5) | 6494 (12.6) | 8811 (17.1) | 6753 (13.1) | 5522 (10.7) | 8292 (16.1) | 4955 (9.6) | 1746 (3.4) | 3503 (6.8) |
Socio-demographic factors | |||||||||
Age, per 5 years higher age | 0.63 (0.60−0.66)** | 0.83 (0.79−0.87)** | Ref | 0.79 (0.76−0.83)** | 0.96 (0.92−1.01) | 1.27 (1.22−1.33)** | 1.17 (1.12−1.23)** | 0.98 (0.91−1.05) | 1.44 (1.36−1.52)** |
Women | 0.63 (0.58−0.68)** | 0.40 (0.37−0.43)** | Ref | 0.38 (0.36−0.41)** | 0.61 (0.57−0.66)** | 0.55 (0.52−0.59)** | 0.23 (0.21−0.25)** | 0.54 (0.48−0.60)** | 0.28 (0.26−0.31)** |
Non-white ethnicity | 1.00 (0.73−1.36) | 1.74 (1.34−2.25)** | Ref | 0.89 (0.66−1.20) | 1.67 (1.28−2.19)** | 0.83 (0.62−1.10) | 1.93 (1.47−2.54)** | 2.24 (1.59−3.14)** | 1.27 (0.92−1.76) |
Lower secondary school or less | 1.24 (1.11−1.39)** | 1.10 (0.99−1.23) | Ref | 1.18 (1.06−1.31)** | 0.90 (0.80−1.01) | 0.98 (0.88−1.08) | 0.96 (0.86−1.02) | 0.91 (0.76−1.09) | 0.91 (0.80−1.04) |
Not married/cohabiting | 1.12 (1.02−1.24)* | 1.28 (1.17−1.40)** | Ref | 1.35 (1.23−1.47)** | 1.49 (1.37−1.64)** | 1.18 (1.09−1.29)** | 1.50 (1.36−1.65)** | 1.38 (1.20−1.58)** | 1.85 (1.66−2.05)** |
In employment | 0.98 (0.91−1.06) | 1.09 (1.01−1.17)* | Ref | 0.88 (0.82−0.95)** | 0.98 (0.91−1.06) | 0.93 (0.86−0.99)* | 0.98 (0.90−1.07) | 1.26 (1.12−1.42)** | 0.87 (0.79−0.96)** |
Townsend deprivation index | |||||||||
Tertile 1 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Tertile 2 | 0.97 (0.89−1.05) | 1.00 (0.93−1.08) | Ref | 0.96 (0.89−1.04) | 0.96 (0.89−1.05) | 0.99 (0.92−1.07) | 1.03 (0.94−1.13) | 0.97 (0.86−1.11) | 0.99 (0.89−1.10) |
Tertile 3 | 0.94 (0.86−1.03) | 1.09 (1.01−1.19)* | Ref | 1.10 (1.02−1.19)* | 1.33 (1.22−1.45)** | 1.17 (1.08−1.26)** | 1.36 (1.24−1.48)** | 1.22 (1.07−1.39)** | 1.59 (1.44−1.77)** |
Behavioural factors | |||||||||
Smoking | |||||||||
Never smokers | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Ex-smokers | 1.09 (1.01−1.17)** | 1.14 (1.07−1.23)** | Ref | 0.96 (0.90−1.03) | 1.18 (1.10−1.27)** | 0.94 (0.88−1.01) | 1.07 (0.99−1.16)** | 1.04 (0.93−1.16) | 1.01 (0.93−1.11) |
Smokers | 0.71 (0.59−0.86)** | 1.19 (1.02−1.38)* | Ref | 0.64 (0.54−0.76)** | 1.87 (1.61−2.17)** | 1.14 (0.98−1.32) | 1.71 (1.47−2.00)** | 1.36 (1.08−1.71)** | 2.65 (2.25−3.12)** |
Alcohol consumption | |||||||||
No consumption | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
1−14 units/week | 0.95 (0.86−1.04) | 1.03 (0.94−1.13) | Ref | 1.07 (0.98−1.17) | 0.94 (0.86−1.03) | 0.95 (0.87−1.03) | 0.93 (0.84−1.02) | 0.97 (0.84−1.11) | 0.68 (0.61−0.75)** |
> 14 units/week | 1.07 (0.98−1.18) | 1.24 (1.14−1.36)** | Ref | 1.13 (1.03−1.23)** | 0.97 (0.88−1.06) | 0.90 (0.83−0.97)* | 1.10 (0.99−1.21) | 1.03 (0.89−1.18) | 0.68 (0.61−0.76)** |
Fruits and vegetables <twice/day | 0.83 (0.72−0.96)** | 1.11 (0.99−1.26) | Ref | 0.99 (0.88−1.12) | 1.41 (1.25−1.60)** | 1.24 (1.11−1.39)** | 1.42 (1.25−1.60)** | 1.04 (0.86−1.26) | 1.68 (1.47−1.92)** |
Daily % >1000 lux, per 1 SD higher exposure | 1.27 (1.22−1.32)** | 1.08 (1.04−1.12)** | Ref | 0.99 (0.96−1.03) | 0.81 (0.78−0.85)** | 0.82 (0.79−0.85)** | 0.87 (0.83−0.91)** | 0.94 (0.88−0.996)* | 0.68 (0.64−0.71)** |
Health-related factors | |||||||||
BMI, per 5 km/m2 higher BMI | 0.58 (0.55−0.61)** | 0.95 (0.91−0.99)* | Ref | 0.87 (0.83−0.91)** | 1.41 (1.35−1.47)** | 1.50 (1.45−1.56)** | 1.62 (1.55−1.69)** | 1.20 (1.12−1.28)** | 2.13 (2.03−2.23)** |
Diabetes | 0.77 (0.62−0.97)* | 0.93 (0.77−1.11) | Ref | 0.74 (0.61−0.90)** | 1.26 (1.06−1.48)** | 1.34 (1.15−1.56)** | 1.50 (1.28−1.75)** | 1.30 (1.01−1.66)* | 2.19 (1.87−2.57)** |
Hypertension | 1.01 (0.93−1.08) | 1.05 (0.98−1.13) | Ref | 1.09 (1.02−1.17)* | 1.09 (1.02−1.18)* | 1.14 (1.07−1.22)** | 1.19 (1.10−1.29)** | 0.93 (0.84−1.04) | 1.27 (1.15−1.39)** |
Hyperlipidaemia | 0.96 (0.89−1.03) | 1.03 (0.96−1.10) | Ref | 1.03 (0.96−1.10) | 1.08 (1.00−1.16)* | 1.08 (1.01−1.15)* | 1.04 (0.96−1.12) | 0.92 (0.82−1.03) | 1.12 (1.03−1.23)** |
Prevalence of ≥1 chronic diseasesb | 0.90 (0.84−0.97)** | 0.98 (0.92−1.06) | Ref | 0.90 (0.84−0.96)** | 1.17 (1.08−1.26)** | 1.09 (1.02−1.16)* | 1.13 (1.05−1.22)** | 1.07 (0.95−1.19) | 1.43 (1.31−1.56)* |
CNS medication | 0.85 (0.72−1.00) | 0.97 (0.84−1.13) | Ref | 1.02 (0.87−1.18) | 1.42 (1.24−1.63)** | 1.18 (1.03−1.34)* | 1.11 (0.94−1.29) | 1.18 (0.94−1.47) | 1.37 (1.17−1.61)** |